CHAD ALLEN: Open Payments
NPI 1780293266 · ASHEBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$594 in 35 payments from 15 companies in 2025. Trend: 2023 $2,390 · 2024 $1,474 · 2025 $594
Food & beverage: $594
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $179 |
| ABBVIE INC. | 4 | $72 |
| Lilly USA, LLC | 3 | $59 |
| Amgen Inc. | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Astellas Pharma US Inc | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Indivior Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: Ozempic, Wegovy, MOUNJARO, VRAYLAR, CAPLYTA, QULIPTA, Veozah, KRYSTEXXA.
Industry payments across NC — which companies pay providers there.
